Cellectis

Forecast & Rating6 analysts currently cover Cellectis, with about 33.3% giving a positive rating — meaning they expect the stock to rise. The average price target is $5.33, about 287.3% upside from the current price of $1.38. Price targets range from $1.30 to $10.00 — a wide spread, showing clear disagreement over just how much Cellectis can rise. Historically, about 0.9% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Cellectis's outlook. Data as of Sep 16, 2026; for reference only and not investment advice.